Events

IATDMCT 2013 13th International Congress of TDM & Clinical Toxicology
September 22 – 26, 2013
Salt Lake City, USA



 12th International Congress of TDM & Clinical Toxicology
October 2 - 6, 2011
Stuttgart Germany
View photos from the Congress!

Login

Forgot Password

Our aims are:

  • Foster and promote education and research in therapeutic drug monitoring and clinical toxicology;

  • Improve the standards of practice and clinical interpretation of drug and toxic substance analyses and facilitate the delivery of interpretation through clinical pharmacokinetics and toxicokinetics for enhanced patient care;

  • Encourage cooperation with and among members of all professions concerned with TDM and clinical toxicology;

  • Encourage the effective application of therapeutic drug monitoring to optimize clinical drug use and maximize the clinical and economic benefits;

  • Encourage progress in clinical toxicology as a diagnostic tool and therapeutic aid for therapeutic drug overdoses, drug abuse, and exposure to environmental toxicants.


Application form (PDF

Definition of TDM


IATDMCT Needs You! - Click here!

Journal

Therapeutic Drug Monitoring is the official journal of IATDMCT

IATDMCT members have free on-line access to the journal Therapeutic Drug Monitoring.

Instructions for authors

IATDMCT YOUNG INVESTIGATORS AWARD

Sponsored by Lippincott Williams & Wilkins

In their meeting of May 27, 2010, the IATDMCT Executive renamed the Young Investigator Award the Victor Armstrong Young Investigator Award in honor of Dr. Armstrong who passed away February 27, 2010.

Terms of Reference

The Award recognizes and encourages the professional development and achievements of a young investigator who has demonstrated exceptional scientific achievements early in his/her career.

  1. The recipient must be a member in good standing of the Association on the day of the award presentation. She/he must be 40 years of age or younger on the date specified as the deadline for receipt of nominations.
  2. The Award shall usually be presented bi-annually, but if in the opinion of the Awards Committee no suitable candidate is available, the Award shall not be presented.
  3. The Award shall be accompanied by a framed certificate and an honorarium in the amount of USD 1,000.
  4. The recipient of the Award shall be chosen by the Awards Committee and approved by the IATDMCT Executive no later than four (4) months prior to the Congress at which the Award will be presented. In order to avoid a conflict of interest, the Awards Committee must no communicate with the IATDMCT Executive or Council on their selection prior to making their final decision. However, the final Awards Committee decision requires the approval of the IATDMCT Executive.
  5. Members of IATDMCT may propose suitable candidates to the Awards Committee through the Business Office of the association.
  6. Nominations from the membership must be accompanied by a curriculum vitae including a list of publications, and a letter from the nominator containing an evaluation of the originality and importance of the candidate's contributions to therapeutic drug monitoring and/or clinical toxicology. Additional letters of support by members of the Association or other respected scientists are helpful for the Selection Committee.
  7. The presentation of the Award shall normally be at the Opening Ceremonies of the Congress of the association. The recipient of the Award is not usually expected to give an address or present a paper.
  8. Recipients of the Victor Armstrong Young Investigator's Award:

    1993 Randall Yatscoff, Canada
    1995 Uwe Christians, Germany
    1997 Amitava Dasgupta, USA
    1999 Ekkehard Schütz, Germany
    2001 Pierre Marquet, France
    2003 Paul Taylor, Australia
    2005 Maria Shipkova, Germany
    2007 Vanessa Steenkamp, South Africa
    2009 Frank Peters, Germany
    2011 Dennis Hesselink, Netherlands

     For more information on IATDMCT Awards, contact the Business Office: office@iatdmct.org

Powered By Dragonfly IT Ltd.